Dental supply company Henry Schein has received a strategic investment from KKR, a global investment firm, according to a Jan. 29 news release.
Here are five things to know:
1. KKR will make a $250 million investment into Henry Schein's common stock on top of its existing holdings.
2. With the investment, KKR will have a 12% position in Henry Schein, making it the largest non-index fund shareholder in the company.
3. The investment firm will also have the option to buy additional shares through open market purchases up to a total equity stake of 14.9%.
4. Under the agreement between the two companies, Max Lin and William Daniel will join Henry Schein's board of directors.
5. Henry Schein and KKR will collaborate to focus on driving strategic growth, operational efficiency and capital allocation.